Analyst Price Targets — DCTH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 7, 2026 10:15 am | — | H.C. Wainwright | $32.00 | $15.47 | TheFly | Delcath Systems price target raised to $32 from $30 at H.C. Wainwright |
| July 13, 2026 11:17 am | — | BTIG | $17.00 | $13.01 | TheFly | Delcath Systems price target raised to $17 from $16 at BTIG |
| February 26, 2026 6:15 pm | — | Evercore ISI | $27.00 | $9.17 | StreetInsider | Delcath Systems (DCTH) PT Lowered to $27 at Clear Street |
| February 26, 2026 4:54 pm | Marie Thibault | BTIG | $19.00 | $9.17 | StreetInsider | Delcath Systems (DCTH) PT Lowered to $19 at BTIG |
| October 21, 2025 1:03 pm | Chase Knickerbocker | Craig-Hallum | $20.00 | $11.42 | TheFly | Delcath Systems price target lowered to $20 from $24 at Craig-Hallum |
| October 20, 2025 2:12 pm | — | H.C. Wainwright | $30.00 | $10.97 | TheFly | Delcath Systems price target lowered to $30 from $31 at H.C. Wainwright |
| March 7, 2025 11:11 am | — | H.C. Wainwright | $24.00 | $13.00 | TheFly | Delcath Systems price target raised to $24 from $22 at H.C. Wainwright |
| May 15, 2024 7:22 am | Swayampakula Ramakanth | H.C. Wainwright | $22.00 | $7.54 | StreetInsider | Delcath Systems (DCTH) PT Raised to $22 at H.C. Wainwright |
Latest News for DCTH
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:Wells Fargo Healthcare Conference on Thursday, September 10, 2026, in Boston, MAH.C. Wainwright 27th Annual Global Investment Conference on Tuesday,…
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
The average of price targets set by Wall Street analysts indicates a potential upside of 52.4% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DCTH.
U.S. House Trading
No House trades found for DCTH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.